Tag Archives: Ukoniq

Cancer Drug Copiktra Linked To Increased Risk of Death, FDA Warns

July 01, 2022 By: Martha Garcia

The FDA warns the cancer drug, Copiktra, may be linked to an increased risk of death among patients.
Ukoniq Side Effects Linked to Increased Risk of Death, FDA Warns, Withdraws Drug Approval

June 03, 2022 By: Irvin Jackson

The FDA has withdrawn approval for the lymphoma drug Ukoniq after determining the risk of death outweighs any potential benefits.
Ukoniq FDA Warning Issued Over Increased Risk of Death with Cancer Drug

February 04, 2022 By: Irvin Jackson

The FDA warns that the relatively new cancer drug, Ukoniq, may increase the risk of death in the lymphoma patients it was designed to treat.

Framework for Talcum Powder Science Day Before New MDL Judge Proposed by Parties (Posted 6 days ago)

The new federal judge overseeing all talcum powder lawsuits has called for a Science Day to educate the court ahead of planned Daubert hearings which could decide if bellwether test trials can move forward.

Tepezza Hearing Complaints Known By Drug Maker For Years Before Warnings Provided, According to Lawsuits (Posted 7 days ago)

Plaintiffs filing Tepezza hearing loss lawsuits claim Horizon Therapeutics, the manufacturer, knew for years that the thyroid eye disease was linked to widespread reports of hearing problems.

Dept. of Justice Outlines Option to Settle Camp Lejeune Lawsuits More Quickly (Posted 13 days ago)

The U.S. government has outlined requirements for qualifying for Camp Lejeune elective option settlement offers.

Tag Archives: Ukoniq

Cancer Drug Copiktra Linked To Increased Risk of Death, FDA Warns

Ukoniq Side Effects Linked to Increased Risk of Death, FDA Warns, Withdraws Drug Approval

Ukoniq FDA Warning Issued Over Increased Risk of Death with Cancer Drug

More Top Stories

Review A Case